IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-31574-z.html
   My bibliography  Save this article

The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors

Author

Listed:
  • Jasmin Bartl

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf
    Institute of Zoology University of Hamburg)

  • Marco Zanini

    (Institut Curie, PSL Research University, CNRS UMR, INSERM
    Université Paris Sud, Université Paris-Saclay, CNRS UMR, INSERM U)

  • Flavia Bernardi

    (Institut Curie, PSL Research University, CNRS UMR, INSERM
    Université Paris Sud, Université Paris-Saclay, CNRS UMR, INSERM U)

  • Antoine Forget

    (Institut Curie, PSL Research University, CNRS UMR, INSERM
    Université Paris Sud, Université Paris-Saclay, CNRS UMR, INSERM U)

  • Lena Blümel

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Julie Talbot

    (Institut Curie, PSL Research University, CNRS UMR, INSERM
    Université Paris Sud, Université Paris-Saclay, CNRS UMR, INSERM U)

  • Daniel Picard

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Nan Qin

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Gabriele Cancila

    (Institut Curie, PSL Research University, CNRS UMR, INSERM
    Université Paris Sud, Université Paris-Saclay, CNRS UMR, INSERM U)

  • Qingsong Gao

    (St Jude Children’s Research Hospital)

  • Soumav Nath

    (Heinrich Heine University
    IBI- (Strukturbiochemie) and JuStruct, Forschungszentrum Jülich)

  • Idriss Mahoungou Koumba

    (Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf)

  • Marietta Wolter

    (Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • François Kuonen

    (Stanford University School of Medicine
    Lausanne University Hospital Center, CH- Lausanne)

  • Maike Langini

    (Heinrich Heine University)

  • Thomas Beez

    (Heinrich Heine University)

  • Christopher Munoz

    (Heinrich Heine University)

  • David Pauck

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Viktoria Marquardt

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Hua Yu

    (Institut Curie, PSL Research University, CNRS UMR, INSERM
    Université Paris Sud, Université Paris-Saclay, CNRS UMR, INSERM U)

  • Judith Souphron

    (Institut Curie, PSL Research University, CNRS UMR, INSERM
    Université Paris Sud, Université Paris-Saclay, CNRS UMR, INSERM U)

  • Mascha Korsch

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Christina Mölders

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Daniel Berger

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Sarah Göbbels

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Frauke-Dorothee Meyer

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Björn Scheffler

    (partner site University Hospital Essen)

  • Barak Rotblat

    (Ben-Gurion University of the Negev
    The National Institute for Biotechnology in the Negev)

  • Sven Diederichs

    (University of Freiburg, DKTK, partner site Freiburg
    Division of RNA Biology & Cancer, DKFZ)

  • Vijay Ramaswamy

    (The Hospital for Sick Children
    The Hospital for Sick Children)

  • Hiromishi Suzuki

    (The Hospital for Sick Children)

  • Anthony Oro

    (Stanford University School of Medicine
    Stanford University)

  • Kai Stühler

    (Heinrich Heine University)

  • Anja Stefanski

    (Heinrich Heine University)

  • Ute Fischer

    (Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf)

  • Gabriel Leprivier

    (Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Dieter Willbold

    (Heinrich Heine University
    IBI- (Strukturbiochemie) and JuStruct, Forschungszentrum Jülich)

  • Gerhard Steger

    (Heinrich Heine University)

  • Alexander Buell

    (Technical University of Denmark)

  • Marcel Kool

    (Hopp Children´s Cancer Center (KiTZ)
    Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
    Princess Máxima Center for Pediatric Oncology)

  • Peter Lichter

    (Division of Molecular Genetics, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), and National Center for Tumor Diseases (NCT))

  • Stefan M. Pfister

    (Hopp Children´s Cancer Center (KiTZ)
    Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
    Heidelberg University Hospital)

  • Paul A. Northcott

    (St Jude Children’s Research Hospital)

  • Michael D. Taylor

    (The Hospital for Sick Children
    The Hospital for Sick Children
    University of Toronto
    The Hospital for Sick Children)

  • Arndt Borkhardt

    (Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf)

  • Guido Reifenberger

    (Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

  • Olivier Ayrault

    (Institut Curie, PSL Research University, CNRS UMR, INSERM
    Université Paris Sud, Université Paris-Saclay, CNRS UMR, INSERM U)

  • Marc Remke

    (Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf
    Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf)

Abstract

Most lncRNAs display species-specific expression patterns suggesting that animal models of cancer may only incompletely recapitulate the regulatory crosstalk between lncRNAs and oncogenic pathways in humans. Among these pathways, Sonic Hedgehog (SHH) signaling is aberrantly activated in several human cancer entities. We unravel that aberrant expression of the primate-specific lncRNA HedgeHog Interacting Protein-AntiSense 1 (HHIP-AS1) is a hallmark of SHH-driven tumors including medulloblastoma and atypical teratoid/rhabdoid tumors. HHIP-AS1 is actively transcribed from a bidirectional promoter shared with SHH regulator HHIP. Knockdown of HHIP-AS1 induces mitotic spindle deregulation impairing tumorigenicity in vitro and in vivo. Mechanistically, HHIP-AS1 binds directly to the mRNA of cytoplasmic dynein 1 intermediate chain 2 (DYNC1I2) and attenuates its degradation by hsa-miR-425-5p. We uncover that neither HHIP-AS1 nor the corresponding regulatory element in DYNC1I2 are evolutionary conserved in mice. Taken together, we discover an lncRNA-mediated mechanism that enables the pro-mitotic effects of SHH pathway activation in human tumors.

Suggested Citation

  • Jasmin Bartl & Marco Zanini & Flavia Bernardi & Antoine Forget & Lena Blümel & Julie Talbot & Daniel Picard & Nan Qin & Gabriele Cancila & Qingsong Gao & Soumav Nath & Idriss Mahoungou Koumba & Mariet, 2022. "The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
  • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31574-z
    DOI: 10.1038/s41467-022-31574-z
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-31574-z
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-022-31574-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Silvana Konermann & Mark D. Brigham & Alexandro E. Trevino & Julia Joung & Omar O. Abudayyeh & Clea Barcena & Patrick D. Hsu & Naomi Habib & Jonathan S. Gootenberg & Hiroshi Nishimasu & Osamu Nureki &, 2015. "Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex," Nature, Nature, vol. 517(7536), pages 583-588, January.
    2. Giles Robinson & Matthew Parker & Tanya A. Kranenburg & Charles Lu & Xiang Chen & Li Ding & Timothy N. Phoenix & Erin Hedlund & Lei Wei & Xiaoyan Zhu & Nader Chalhoub & Suzanne J. Baker & Robert Hueth, 2012. "Novel mutations target distinct subgroups of medulloblastoma," Nature, Nature, vol. 488(7409), pages 43-48, August.
    3. Nian Liu & Qing Dai & Guanqun Zheng & Chuan He & Marc Parisien & Tao Pan, 2015. "N6-methyladenosine-dependent RNA structural switches regulate RNA–protein interactions," Nature, Nature, vol. 518(7540), pages 560-564, February.
    4. Joan Massagué, 2004. "G1 cell-cycle control and cancer," Nature, Nature, vol. 432(7015), pages 298-306, November.
    5. Hiromichi Suzuki & Sachin A. Kumar & Shimin Shuai & Ander Diaz-Navarro & Ana Gutierrez-Fernandez & Pasqualino Antonellis & Florence M. G. Cavalli & Kyle Juraschka & Hamza Farooq & Ichiyo Shibahara & M, 2019. "Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma," Nature, Nature, vol. 574(7780), pages 707-711, October.
    6. Sebastian M. Waszak & Giles W, Robinson & Brian L. Gudenas & Kyle S. Smith & Antoine Forget & Marija Kojic & Jesus Garcia-Lopez & Jennifer Hadley & Kayla V. Hamilton & Emilie Indersie & Ivo Buchhalter, 2020. "Germline Elongator mutations in Sonic Hedgehog medulloblastoma," Nature, Nature, vol. 580(7803), pages 396-401, April.
    7. Esther Rheinbay & Prasanna Parasuraman & Jonna Grimsby & Grace Tiao & Jesse M. Engreitz & Jaegil Kim & Michael S. Lawrence & Amaro Taylor-Weiner & Sergio Rodriguez-Cuevas & Mara Rosenberg & Julian Hes, 2017. "Recurrent and functional regulatory mutations in breast cancer," Nature, Nature, vol. 547(7661), pages 55-60, July.
    8. Paul A. Northcott & Ivo Buchhalter & A. Sorana Morrissy & Volker Hovestadt & Joachim Weischenfeldt & Tobias Ehrenberger & Susanne Gröbner & Maia Segura-Wang & Thomas Zichner & Vasilisa A. Rudneva & Ha, 2017. "The whole-genome landscape of medulloblastoma subtypes," Nature, Nature, vol. 547(7663), pages 311-317, July.
    9. Weiqi Zhang & Haifeng Wan & Guihai Feng & Jing Qu & Jiaqiang Wang & Yaobin Jing & Ruotong Ren & Zunpeng Liu & Linlin Zhang & Zhiguo Chen & Shuyan Wang & Yong Zhao & Zhaoxia Wang & Yun Yuan & Qi Zhou &, 2018. "SIRT6 deficiency results in developmental retardation in cynomolgus monkeys," Nature, Nature, vol. 560(7720), pages 661-665, August.
    10. Jonathan J. Kotzin & Sean P. Spencer & Sam J. McCright & Dinesh B. Uthaya Kumar & Magalie A. Collet & Walter K. Mowel & Ellen N. Elliott & Asli Uyar & Michelle A. Makiya & Margaret C. Dunagin & Christ, 2016. "The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan," Nature, Nature, vol. 537(7619), pages 239-243, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Samuel Rivero-Hinojosa & Melanie Grant & Aswini Panigrahi & Huizhen Zhang & Veronika Caisova & Catherine M. Bollard & Brian R. Rood, 2021. "Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    2. Zaili Luo & Dazhuan Xin & Yunfei Liao & Kalen Berry & Sean Ogurek & Feng Zhang & Liguo Zhang & Chuntao Zhao & Rohit Rao & Xinran Dong & Hao Li & Jianzhong Yu & Yifeng Lin & Guoying Huang & Lingli Xu &, 2023. "Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    3. Michelle M. Kameda-Smith & Helen Zhu & En-Ching Luo & Yujin Suk & Agata Xella & Brian Yee & Chirayu Chokshi & Sansi Xing & Frederick Tan & Raymond G. Fox & Ashley A. Adile & David Bakhshinyan & Kevin , 2022. "Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    4. Heathcliff Dorado García & Fabian Pusch & Yi Bei & Jennifer Stebut & Glorymar Ibáñez & Kristina Guillan & Koshi Imami & Dennis Gürgen & Jana Rolff & Konstantin Helmsauer & Stephanie Meyer-Liesener & N, 2022. "Therapeutic targeting of ATR in alveolar rhabdomyosarcoma," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    5. Xiangfeng Kong & Hainan Zhang & Guoling Li & Zikang Wang & Xuqiang Kong & Lecong Wang & Mingxing Xue & Weihong Zhang & Yao Wang & Jiajia Lin & Jingxing Zhou & Xiaowen Shen & Yinghui Wei & Na Zhong & W, 2023. "Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    6. Jian Wang & Yuxi Teng & Ruihua Zhang & Yifei Wu & Lei Lou & Yusong Zou & Michelle Li & Zhong-Ru Xie & Yajun Yan, 2021. "Engineering a PAM-flexible SpdCas9 variant as a universal gene repressor," Nature Communications, Nature, vol. 12(1), pages 1-10, December.
    7. Alexander Martinez-Fundichely & Austin Dixon & Ekta Khurana, 2022. "Modeling tissue-specific breakpoint proximity of structural variations from whole-genomes to identify cancer drivers," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    8. Ulrik Kristoffer Stoltze & Jon Foss-Skiftesvik & Thomas van Overeem Hansen & Simon Rasmussen & Konrad J. Karczewski & Karin A. W. Wadt & Kjeld Schmiegelow, 2024. "The evolutionary impact of childhood cancer on the human gene pool," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    9. David R. Ghasemi & Konstantin Okonechnikov & Anne Rademacher & Stephan Tirier & Kendra K. Maass & Hanna Schumacher & Piyush Joshi & Maxwell P. Gold & Julia Sundheimer & Britta Statz & Ahmet S. Rifaiog, 2024. "Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    10. Silvia Pomella & Matteo Cassandri & Lucrezia D’Archivio & Antonella Porrazzo & Cristina Cossetti & Doris Phelps & Clara Perrone & Michele Pezzella & Antonella Cardinale & Marco Wachtel & Sara Aloisi &, 2023. "MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting," Nature Communications, Nature, vol. 14(1), pages 1-23, December.
    11. Wenan Chen & Shuoguo Wang & Saima Sultana Tithi & David W. Ellison & Daniel J. Schaid & Gang Wu, 2022. "A rare variant analysis framework using public genotype summary counts to prioritize disease-predisposition genes," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    12. Arpiar Saunders & Kee Wui Huang & Cassandra Vondrak & Christina Hughes & Karina Smolyar & Harsha Sen & Adrienne C. Philson & James Nemesh & Alec Wysoker & Seva Kashin & Bernardo L. Sabatini & Steven A, 2022. "Ascertaining cells’ synaptic connections and RNA expression simultaneously with barcoded rabies virus libraries," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    13. William C. W. Chen & Leonid Gaidukov & Yong Lai & Ming-Ru Wu & Jicong Cao & Michael J. Gutbrod & Gigi C. G. Choi & Rachel P. Utomo & Ying-Chou Chen & Liliana Wroblewska & Manolis Kellis & Lin Zhang & , 2022. "A synthetic transcription platform for programmable gene expression in mammalian cells," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    14. Julia Joung & Paul C. Kirchgatterer & Ankita Singh & Jang H. Cho & Suchita P. Nety & Rebecca C. Larson & Rhiannon K. Macrae & Rebecca Deasy & Yuen-Yi Tseng & Marcela V. Maus & Feng Zhang, 2022. "CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    15. Zhiyuan Luo & Qilian Ma & Shan Sun & Ningning Li & Hongfeng Wang & Zheng Ying & Shengdong Ke, 2023. "Exon-intron boundary inhibits m6A deposition, enabling m6A distribution hallmark, longer mRNA half-life and flexible protein coding," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    16. Jifeng Yu & Bangguo Zhou & Shen Zhang & Haohao Yin & Liping Sun & Yinying Pu & Boyang Zhou & Yikang Sun & Xiaolong Li & Yan Fang & Lifan Wang & Chongke Zhao & Dou Du & Yan Zhang & Huixiong Xu, 2022. "Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    17. Liam McAllan & Damir Baranasic & Sergio Villicaña & Scarlett Brown & Weihua Zhang & Benjamin Lehne & Marco Adamo & Andrew Jenkinson & Mohamed Elkalaawy & Borzoueh Mohammadi & Majid Hashemi & Nadia Fer, 2023. "Integrative genomic analyses in adipocytes implicate DNA methylation in human obesity and diabetes," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    18. Suijuan Zhong & Mengdi Wang & Luwei Huang & Youqiao Chen & Yuxin Ge & Jiyao Zhang & Yingchao Shi & Hao Dong & Xin Zhou & Bosong Wang & Tian Lu & Xiaoxi Jing & Yufeng Lu & Junjing Zhang & Xiaoqun Wang , 2023. "Single-cell epigenomics and spatiotemporal transcriptomics reveal human cerebellar development," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    19. Melanie Schoof & Shweta Godbole & Thomas K. Albert & Matthias Dottermusch & Carolin Walter & Annika Ballast & Nan Qin & Marlena Baca Olivera & Carolin Göbel & Sina Neyazi & Dörthe Holdhof & Catena Kre, 2023. "Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    20. Ainara González-Iglesias & Aida Arcas & Ana Domingo-Muelas & Estefania Mancini & Joan Galcerán & Juan Valcárcel & Isabel Fariñas & M. Angela Nieto, 2024. "Intron detention tightly regulates the stemness/differentiation switch in the adult neurogenic niche," Nature Communications, Nature, vol. 15(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31574-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.